Immunome (IMNM) Enterprise Value (2020 - 2026)
Immunome's Enterprise Value was $1.88 billion in Q2 2026, up 248.0% from $541.14 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Enterprise Value (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immunome's Enterprise Value was $374.1 million through Jun 30, 2026; for FY2025, it came in at $1.22 billion, up 161.7% from FY2024.
- In earlier years, Enterprise Value was $467.27 million in FY2024 (+529.9%), $74.19 million in FY2023, $6.48 million in FY2022 (-94.0%) and $107.72 million in FY2021.
- Quarterly Enterprise Value has moved between $4.28 million (Q2 2022) and $1.89 billion (Q1 2026) over five years.
- Compared with a year earlier, Enterprise Value has increased for five straight quarters, with growth averaging 216.3% over the last seven quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2024 (growth of 670.9%); the worst was Q2 2022 (a decline of 97.0%).
- Per Business Quant data, IMNM's Enterprise Value in the three quarters before Q2 2026 was $1.89 billion (Q1 2026), $1.22 billion (Q4 2025) and $801.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Immunome | 2.46 Bn | 429.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Bn |
| Mar 31, 2026 | 1.89 Bn |
| Dec 31, 2025 | 1.22 Bn |
| Sep 30, 2025 | 801.25 Mn |
| Jun 30, 2025 | 541.14 Mn |
| Mar 31, 2025 | 267.89 Mn |
| Dec 31, 2024 | 467.27 Mn |
| Sep 30, 2024 | 643.20 Mn |
| Jun 30, 2024 | 447.81 Mn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 74.19 Mn |
| Sep 30, 2023 | 11.25 Mn |
| Jun 30, 2023 | 58.09 Mn |
| Mar 31, 2023 | 16.42 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Sep 30, 2022 | 26.77 Mn |
| Jun 30, 2022 | 4.28 Mn |
| Mar 31, 2022 | 26.00 Mn |
| Dec 31, 2021 | 107.72 Mn |
| Sep 30, 2021 | 238.23 Mn |
API Access
Immunome Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();